President of Radiometer resigns - replacement in place

Henrik Schimmell, president and chairman of Radiometer, is stepping down after 15 years with the company.

Chairman and President of medical device company Radiometer, Henrik Schimmell, is stepping down after 15 years with the company, the last eight as CEO.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

Access all locked articles
Receive our daily newsletters
Access our app

Get full access for you and your coworkers

Start a free company trial today

Danaher shelves its takeover pursuit of Catalent
For subscribers
Drug contractor Catalent plunges after annual guidance cut, results delayed
For subscribers

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Eric Bernard, outgoing CEO of WS Audiology | Foto: Ws Audiology / Pr

Hearing health

Outgoing WSA CEO: This could have been better

The start up of the new factory in Mexico could have been done better, and the supply of products of the right quality at the right time suffered, admits outgoing WSA CEO Eric Bernard.

For subscribers

OTC addresses mild to moderate hearing loss and can push older, low-quality products out of the market. | Foto: Alan Youngblood/AP/Ritzau Scanpix

Hearing health

WSA sees OTC hearing aids pushing previous category completely off the table

For subscribers

Zealand Pharma has crucial study data on the way for its obesity candidate. | Foto: Martin Lehmann

Pharma & biotech

Zealand Pharma hopes for 7-9 percent weight loss in important study - may open up dialogues

For subscribers

Charl van Zyl, CE, Lundbeck. | Foto: Magnus Møller

Pharma & biotech

Eradication of Lundbeck's net debt "proves underlying strength," says CEO

For subscribers

The price of obesity drugs like Wegovy should be set so that patients with the necessary medical need have access to it, according to a former top scientist at the company - just as the industry has worked to do with insulin. | Foto: Hollie Adams

Pharma & biotech

Former Novo Nordisk VP criticizes price of obesity drugs: "The only thing Novo Nordisk doesn't want to hear"

For subscribers

Pharma & biotech

Alexion wants to return Zealand Pharma candidate

For subscribers

Roche's obesity candidate achieves significant weight loss in phase I trial
Roche reports an average placebo-adjusted weight loss of 18.8%.
WSA reports slightly slower growth in second quarter
The pace of hearing company WS Audiology’s growth has slowed down compared to the preceding quarter and the same period last year — but still equated to 7% in Q2.
For subscribers
Novo Nordisk's head of development sells shares for USD 1.2m
Martin Holst Lange has sold out of his personal shareholding as head of development at Novo Nordisk.
Genmab CEO warns West's distrust of China could harm pharma industy
Genmab expresses concern about the West’s distrust of the Chinese market and highlights its potential after the proposal of a US bill that could limit collaboration with Chinese biotech companies.
For subscribers
Novo’s Wegovy will bankrupt health system, Senator Bernie Sanders says
“Pricing drugs based on their value cannot serve as a blank check,” a report from majority staff for the Senate Health, Education, Labor and Pensions committee that is led by Sanders states.
For subscribers
Lundbeck's key products surprise positively - Rexulti slightly restrained in the US
In total, the products generated sales of DKK 3759m compared to analysts’ expectations of DKK 3717m.
For subscribers

Former Novo Nordisk VP criticizes price of obesity drugs: "The only thing Novo Nordisk doesn't want to hear"

He believes that the industry should solve the problem of high prices leaving patients in the lurch instead of leaving it to politicians.

For subscribers

Hearing health

WSA sees OTC hearing aids pushing previous category completely off the table

The CEO of WS Audiology predicts that OTC hearing aids will eventually replace poor quality products and revolutionize the industry.

For subscribers

Hearing health

Outgoing WSA CEO: This could have been better

The start up of the new factory in Mexico could have been done better, and the supply of products of the right quality at the right time suffered, admits outgoing WSA CEO Eric Bernard.

For subscribers